Cardiovascular Lifestyle Study: Effects and Expense of a Cardiovascular Risk Reduction Clinic in Primary Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00291824|
Recruitment Status : Unknown
Verified February 2006 by Caroline Medical Group.
Recruitment status was: Recruiting
First Posted : February 15, 2006
Last Update Posted : February 15, 2006
|Condition or disease||Intervention/treatment||Phase|
|Hypertension Hyperlipidemia Hyperglycemia Cardiovascular Disease Smoking||Behavioral: Cardiovascular risk factors and willingness to change||Phase 1|
Background: Uncontrolled hypertension, hyperlipidemia, hyperglycemia, smoking and other cardiovascular risks remain at epidemic proportions despite known efficacious treatments. Issues of both provider and patient behavioral non-adherence to guidelines and therapeutic regimes, respectively, are key factors in non-control. Few interventions aimed at reducing cardiovascular risk factors are based on sound theories of behavior change.
Objective: To assess the effectiveness and expense of three approaches to the care of persons with known risks for cardiovascular disease. The three treatment approaches are usual care, usual care plus nurse telephone calls, and usual care plus clinic visits to a nurse and/or physician.
Design: Patients will be randomized to a 1) specialized proactive, and holistic cardiovascular risk management clinic using principles of behavior change; 2) nurse telephone calls as an attention placebo, yet a low dose, health promotion intervention; and 3) usual primary care. A random sample of 670 patients with cardiovascular risks identified in the past five years will be selected. Patients will be excluded if they do not speak English, are cognitively impaired or live in a nursing home. Interview questionnaires will measure cardiovascular risk, intention to change, social support, depression, coping and health services use. In addition, patients will be required to give a blood sample to measure cholesterol and glucose levels. Patients will then be randomized to one of three treatment groups.
Significance: The expected findings of this study is that the cardiovascular clinic, with nurse and physician, will be most effective at reducing cardiovascular risk and will pay for itself by averting hospital and emergency use for cardiovascular events.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||670 participants|
|Intervention Model:||Factorial Assignment|
|Official Title:||A Randomized Controlled Trial of the Effects and Expense of a Primary and Secondary Cardiovascular Risk Reduction Clinic in Primary Care|
|Study Start Date :||August 2004|
|Study Completion Date :||February 2006|
- Current Interview or Chart
- International classification of diseases
- Characteristics/demographics (dob, gender, marital status, living arrangement, employment, culture, language, spiritual beliefs, concurrent diseases - number/type).
- Cognition: 10 item short portable mental status questionnaire (SPMSQ)(Pfeiffer, 1975)
- Number of MD visits for cardiovascular risk factor
- Percentage change in cardiovascular risk scores over time.
- Percentage of targeted weight and exercise goals achieved (blood pressure control, smoking cessation, weight control, cholesterol control, sugar control, exercise levels). (Grundy, et al, 1999)
- Self efficacy scale (Lorig et al, 1996)
- Social support - personal resource questionnaire 85 (Weinert & Brandt 1987).
- Depression (MADRS)(Montgomery & Asberg 1979) (Montgomery et al 1985) (Browne, Steiner Roberts et al 2002).
- Coping (Moos and Billings 1984)
- Expenditures of health and social services (Browne et al 2001)
- Calculate the number of Framingham points for each risk factor
- Blood samples
- Motivational Interviewing
- Behavior Change
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00291824
|Contact: Michael Mills, MDemail@example.com|
|Caroline Medical Group||Recruiting|
|Burlington, Ontario, Canada, L7R4C7|
|Contact: Michael Mills, MD CCFP|
|Contact: Donna Landry 905.632.8007 ext 103|
|Sub-Investigator: Lori Chalklin, MD CCFP|
|Sub-Investigator: David Wallik, MD CCFP|
|Sub-Investigator: James Kraemer, MD CCFP|
|Sub-Investigator: Stephen Duncan, MD CCFP|
|Sub-Investigator: Chris Williams, MD CCFP|
|Principal Investigator:||Michael Mills, MD CCFP||Caroline Medical Group|